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Abstract
Background: There are few evidence-based mobile health solutions for treating adolescent obesity. The primary
aim of this parallel non-inferiority trial is to assess the effectiveness of an experimental smartphone application in
reducing obesity at 12 months, compared to the Temple Street W82GO Healthy Lifestyles intervention.
Methods/design: The primary outcome measure is change in body mass index standardised deviation score at
12 months. The secondary aim is to compare the effect of treatment on secondary outcomes, including waist
circumference, insulin sensitivity, quality of life, physical activity and psychosocial health. Adolescents with a
body mass index at or above the 98th percentile (12 to 17 years) will be recruited from the Obesity clinic at
Temple Street Children’s University Hospital in Dublin, Ireland. W82GO is a family-based lifestyle change intervention
delivered in two phases over 12 months. In the current study, participants will be randomised for phase two of
treatment to either usual care or care delivered via smartphone application. One hundred and thirty-four participants
will be randomised between the two study arms. An intention-to-treat analysis will be used to compare treatment
differences between the groups at 12 months.
Discussion: The results of this study will be disseminated via open access publication and will provide
important information for clinicians, patients and policy makers regarding the use of mobile health interventions
in the management of adolescent obesity.
Trial registration: Clinicaltrials.gov NCT01804855.
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Background
Childhood obesity in Ireland is a major problem: 19% of
9-year-old children are overweight and 7% are obese [1].
Child and adolescent obesity is associated with multiple
physical and psychological co-morbidities [2] and, al-
though effective treatments are available, there is consid-
erable room for improvement. For example, a Cochrane
Review reported sufficient evidence for the treatment ef-
fect of well-targeted interventions and its meta-analyses
found a reduction in body mass index standardised devi-
ation score (BMI SDS) of 0.14 at 12 months [3].
The Temple Street W82GO Healthy Lifestyles programme
(W82GO) is a family-based multidisciplinary outpatient
treatment for child and adolescent obesity (http://w82go.ie/).
In a prospective study of the W82GO programme, signifi-
cant reductions in BMI SDS have been described after
12 months of treatment [4]. However, although the beneficial
effects of face-to-face family-based treatment have been de-
scribed [5], it remains uncertain whether such treatments
can be effective when delivered to potentially greater num-
bers using a mobile health approach.
Data exist regarding the use of technology [6] and mo-
bile applications in a variety of clinical areas, including
patient support [7], smoking cessation [8], diabetes man-
agement [9], and cardiac rehabilitation [10], but there is
a dearth of data regarding the use of mobile health ap-
proaches in the management of adolescent obesity.
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Aim
The primary aim of this project is to assess the impact
of a smartphone application compared with usual care
on BMI SDS over 12 months in adolescents who are
obese (12 to 17 years). Secondary outcome measures are
waist circumference, insulin sensitivity, quality of life,
physical activity and psychosocial health.
Methods/design
Trial design
Randomised trial of 12 months duration with parallel
groups and assessor blinding.
Participants
Children and adolescents attending Temple Street Chil-
dren’s University Hospital in Dublin Ireland for obesity
management will be recruited. Children are referred to
the obesity clinic by their general practitioner, or pri-
mary healthcare team.
Eligibility criteria
 Inclusion criteria: child aged between 12 and
17 years, child BMI >98th percentile, child fluent in
English, parent(s) willing to participate in the
programme with their child and completion of
written informed consent and assent prior to any
study-specific procedures.
 Exclusion criteria: severe intellectual difficulties
which would limit the child’s ability to engage in
group activity, obesity secondary to genetic
condition, limitations to engaging in physical activity
(for example, active musculoskeletal injury) or use of
medication known to effect body weight, limitations
to using a smartphone device and known family
issues that would affect general compliance and
attendance at follow-up visits.
Recruitment
Children will be recruited from medical clinics and given
written information regarding the study. Families wish-
ing to participate in the study will be asked to complete
parental consent and age-appropriate child assent forms.
The motivation and expectations of both adolescents
and parents will be evaluated and the alternative treat-
ment options will be discussed (such as 1:1 treatment in
outpatient clinic). It will be made clear to parents and
their adolescents that by participating in the study they
will have a 50:50 chance of being treated in a standard
manner or with the smartphone intervention for phase 2
of treatment.
Based on our calculations, we will need to recruit 134
adolescents for randomisation over an enrolment period
of 18 months.
This study will be conducted in agreement with the
‘Declaration of Helsinki’. The study has ethical approval
from The Children’s University Hospital Ethics Board
(11–033). All parents and adolescents will give their
written informed consent. Modifications to this study
protocol will be communicated to all those involved in
the study: data monitoring committee, trial steering com-
mittee, clinical team, study sponsor, and study funders.
Randomisation
Adolescents who are eligible will be randomised to ei-
ther a W82GO (usual care) group or a smartphone ex-
perimental group by the research team using a secure
online randomisation system with full allocation con-
cealment. They will be stratified by gender and parental
obesity, and 134 adolescents will be randomised in total
using a 1:1 randomisation ratio. After randomisation, ad-
olescents will receive a study code, which will be used to
analyse all the data related to that child.
Intervention
Assessment
In keeping with routine practice, adolescents and their
parents are assessed by the multidisciplinary team, which
allows the team to build trust with the family. Assessment
by the multidisciplinary team includes the following.
Paediatrician During this visit, general information is
collected concerning pregnancy, birth, and early child-
hood development. The medical history of the family
and the child is discussed along with any concerns that
the child or parents have. The causal effects of obesity
are discussed along with the medical complications that
exist.
The physical examination investigates the presence of
acanthosis nigricans, possible dysmorphic features, and
hirsutism. Pubertal status is recorded according to Tan-
ner and laboratory tests are requested.
Dietitian In this visit, the nutritional intake of the child
is detailed in tandem with the eating behaviours of the
family. The child is given a food diary to be completed
over two weekend days and one weekday in order to
provide an indication of micro- and macro-nutrient in-
take. The session is also used to introduce information
regarding nutrition and healthy eating behaviour.
Physiotherapist The adolescent undergoes a physical
examination to screen for musculoskeletal problems (for
example, impaired gait or balance) and to measure phys-
ical activity levels, blood pressure, sedentary behaviour,
sleep, cardiorespiratory fitness and quality of life.
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Psychologist This session provides an opportunity for
the family to discuss their motivations for becoming
healthier. The role of the parent is highlighted and prac-
tical strategies to promote a positive environment at
home are discussed. Issues such as body image, bullying
and self esteem are assessed.
Outcomes
Primary outcome
Anthropometric parameters Body weight is measured
to the nearest 0.1 kg using an electronic scale (SECA,
Vogel & Halke, Hamburg, Germany) and height to the
nearest 0.1 cm with a stadiometer (SECA, Vogel &
Halke) in light clothing and without shoes. Measures are
taken in triplicate and mean values calculated. Waist cir-
cumference is measured with an anthropometric tape
midway between the lower rib margin and the iliac crest
at the end of gentle expiration. BMI is calculated as
weight/height squared (kg/m2). Subjects are classified as
obese if they plot above the 98th percentile for BMI on
the Irish growth charts. The primary outcome, BMI
SDS, is calculated using UK reference data (Cole LMS
method).
Secondary outcomes
Blood sample analysis Blood samples are taken by
venipuncture after an overnight fast by an experi-
enced paediatric phlebotomist. Fasting samples are
taken to measure glucose, insulin, total cholesterol,
high density lipoprotein, low density lipoprotein, tri-
glycerides, thyroid function, glycated haemoglobin,
and the liver enzymes aspartate transaminase and ala-
nine transaminase.
Insulin resistance The Homeostasis Assessment Model
for insulin resistance formula [11] is used as an index of
insulin resistance:
fasting insulin mU=mlð Þ  fasting glucose mmol=lð Þð Þ=22:5
Blood pressure Blood pressure measurements (Omron,
Kyoto, Japan) are taken in a relaxed sitting position, in
triplicate. The last measurement is used for analyses [12].
Physical activity Objective measurement of physical ac-
tivity will be completed using 7 days of accelerometry
data (Geneactiv accelerometer, Activinsights, Kimbolton,
UK). The Physical Activity Questionnaire for Adoles-
cents will be used to measure subjective physical activity
in adolescents. This is a 7-day self-report measure,
which is reliable and valid for use in adolescents aged 7
to 19 years [13].
Physical fitness Cardiorespiratory fitness is measured
with a submaximal treadmill test (modified Balke test)
with heart rate, rate of perceived exertion and oxygen
saturation monitoring [14]. The test takes between 10
and 15 minutes or until 85% of the maximum heart rate
is achieved.
Musculoskeletal screen The physiotherapist screens
the musculoskeletal system in order to identify any is-
sues that might cause physical limitation to the child.
The screening procedure has been detailed in full previ-
ously [15]. If there are musculoskeletal concerns identi-
fied, the symptoms will be treated as appropriate. Motor
skill is evaluated using the balance and coordination
subscale of the Bruinnincks Oteresky Test of Motor Pro-
ficiency (Pearson, TX, USA).
Health-related quality of life The Pediatric Quality of
Life Inventory is used as a measure of health-related
quality of life and has been used in obese cohorts pre-
viously [16].
Psychosocial health Social, behavioural and emotional
functioning is assessed using the Child behaviour Check-
list/Youth Self Report [17] and self concept by The Piers
Harris Questionnaire [18].
Treatments
W82GO is underpinned by behavioural change theory
(transtheoretical model and social cognitive theory) and
uses strategies including stimulus control, self-monitoring,
positive reinforcement, goal setting and problem solving
to facilitate lifestyle change. The intervention is described
in full in Additional file 1. W82GO consists of phase 1
and phase 2 treatments.
Phase 1 treatment
Phase 1 is the initial intensive phase and consists of six
weekly sessions (0 to 6 weeks) for adolescents and their
parents. These sessions last 2 hours and incorporate
educational and practical sessions to increase physical
activity, improve nutrition, increase sleep and reduce
obesity.
Phase 2 treatment
Phase 2 is a maintenance phase. Upon completion of
phase 1, participants return with their parents for three
3-monthly booster maintenance sessions over 46 weeks
[4]. These sessions are aimed to encourage the family to
continue with lifestyle change and to manage barriers to
change.
In the current study, having completed phase 1 of
treatment, participants will be randomised for phase 2
to either usual care or smartphone care.
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The smartphone application incorporates evidence-
based behavioural change tools such as self-monitoring,
goal setting, and peer support. Evidence-based tips are
sent to the user in the form of a text tip, a video tip or
an image tip. The tips aim to increase the knowledge of
the participant with regard to healthy eating, physical ac-
tivity, physical fitness and sleep. The user is encouraged
to engage in daily goal setting to increase physical activ-
ity level and sleep, increase water intake, reduce intake
of sugar and fat and to increase intake of fibre, fruits
and vegetables. In addition, the user is encouraged to
monitor their progress by reviewing their goals daily and
by entering their height and weight measurements
(which are charted over time).
Those randomised to usual care will return for three
booster sessions and for measurement of primary and
secondary outcomes at 6 and 12 months. Those in the
smartphone group will use the smarphone app and will
return for measurement of outcomes at 6 to 12 months.
Contact with the participants will be ensured throughout
the study by monthly phone-calls from the principal in-
vestigator. See Figure 1.
Power calculation
This study is a non-inferiority trial to determine whether
a smartphone intervention could be used as a treatment
in adolescent obesity management. The null hypothesis
is that the smartphone intervention will have a positive
effect on BMI SDS but that this change will be inferior
to usual care. Based on a 0.21 reduction of BMI SDS at
12 months, a standard deviation of 0.24 in the usual care
group and a non-inferiority limit of 0.12, the sample size
required at 80% power will be 50 per group or 100 total.
To allow for expected dropout the total number of ado-
lescents to be recruited will be 134.
Blinding
After randomisation and assignment to the study group,
participants will be given a study identification number.
The assessor of the primary outcome will not know the
allocated intervention for the participant, to reduce the
risk of bias. Given the nature of the intervention, it is
not possible to blind the participants or the care pro-
viders. An independent data analyst will be blinded dur-
ing the trial by the use of a fully anonymised dataset.
Electronic health considerations
Given the dynamic nature of electronic health trials,
there may be changes to the methodology after trial
commencement and, if so, these will be detailed in full.
Examples include major bug fixes in the software,
changes in the functionality or content of the application
and any unexpected events that might influence study
outcomes (such as system failures or downtimes).
Data collection and management
Primary and secondary outcome measurement will take
place during initial baseline assessment, at 6 months and
at 12 months. Participants who drop out of the trial will
be invited to attend these follow-up visits for measure-
ment. Data will be stored on password-protected fire-
walled computers, which are accessible only to members
of our research team and those involved in managing
the application software. Blood samples will be labelled
with the patient’s initials and medical record number
and stored in laboratories that are locked when not in
use. With the permission of the participant (or parent/
guardian), the blood samples and information collected
during this research study may be stored indefinitely and
used by our research group for future studies. Any infor-
mation about individual participants derived from the add-
itional studies will be kept confidential. The participant
may at any time request that the blood samples be
destroyed. When the results of the research are published
or discussed in conferences, no information will be in-
cluded that would reveal the identity of any participant un-
less their specific consent had been obtained. Data will be
entered using double-data entry to assure quality control.
Data analysis
All statistical analyses will be performed using SPSS
(version 20, IBM, NY, USA). Descriptive statistics will be
used to characterise demographic, clinical and laboratory
variables. Distributions of primary and secondary out-
comes will be examined using histograms and box plots
for evidence of deviation from a normal distribution. If
the distribution of a continuous outcome variable shows
skewness or other marked departure from normality,
mathematical transformations will be applied before
using inferential techniques that require normality or al-
ternative non-parametric methods (for example, boot-
strap). An intention-to-treat analysis will be used to
measure change in BMI SDS over time between the two
groups and data will be adjusted for baseline age, BMI
and gender.
Data monitoring
A data monitoring committee will insure oversight of
the trial and will meet with the principal investigator
quarterly. This will provide independent review as to
whether study participants are being exposed to unrea-
sonable risks and will monitor study progress and integ-
rity. The data monitoring committee will meet to review
data from the ongoing trial (outcome data and data re-
garding adverse events) and make recommendations to
the trial steering committee. Data will be managed in ac-
cordance withTemple Street Children’s University Hospital
and UCC data protection policies. Any identifiable infor-
mation that is obtained in connection with this study will
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remain confidential and will be disclosed only with the par-
ticipant’s permission or as required by Irish or EU law.
Adverse events
At each visit, participants and their parents will complete
an adverse events form in order to capture any unintended
effects of the trial. Spontaneous reporting of adverse events
will be possible by calling the study phone line.
Discussion
The results of the trial will be communicated to study
participants, research collaborators, funders and the
Figure 1 Study flow chart.
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general public via a scientific publication and lay sum-
mary. The findings are expected to guide further devel-
opment of a telemedicine system for the management of
clinical obesity in adolescence. Ethical concerns specific
to telemedical interventions have been considered such
as the provision of web-enabled devices to minors, en-
suring the security of patient data via online systems,
and the use of devices in healthcare delivery which may
expose a child to radio-frequency electromagnetic fields.
Trial status
Recruiting.
Additional file
Additional file 1: Describes the full content of the evidence-based
Temple Street W82GO Healthy Lifestyle Programme using a
modified intervention mapping approach.
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